Slideshow

August 7, 2018

Narrow Therapeutic Window for GH Replacement in Women

Author(s):

Gregory M. Weiss, MD

How do low- and high-normal levels of IGF-1 impact cognitive function and wellbeing during growth hormone replacement? Answers from a new study.

Related Videos

Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA

Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University

Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego

Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute

Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn

Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University

Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn

Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.